Loading clinical trials...
Loading clinical trials...
Ikervis for Prophylaxis of Dry Eye Disease Due to Graft vs Host Disease Post Allogeneic Haemtopoietic Stem Cell Transplant
Conditions
Interventions
Cyclosporine Ophthalmic
Locations
1
Singapore
Singapore Eye Research Institute
Singapore, Singapore
Start Date
November 28, 2019
Primary Completion Date
August 22, 2022
Completion Date
December 30, 2022
Last Updated
November 19, 2020
Lead Sponsor
Singapore Eye Research Institute
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions